Luque I, Todd M J, Gómez J, Semo N, Freire E
Department of Biology and Biocalorimetry Center, The Johns Hopkins University, Baltimore, Maryland 21218, USA.
Biochemistry. 1998 Apr 28;37(17):5791-7. doi: 10.1021/bi9802521.
The binding thermodynamics of the HIV-1 protease inhibitor acetyl pepstatin and the substrate Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln, corresponding to one of the cleavage sites in the gag, gag-pol polyproteins, have been measured by direct microcalorimetric analysis. The results indicate that the binding of the peptide substrate or peptide inhibitor is entropically driven; i.e., it is characterized by an unfavorable enthalpy and a favorable entropy change, in agreement with a structure-based thermodynamic analysis based upon an empirical parameterization of the energetics. Dissection of the binding enthalpy indicates that the intrinsic interactions are favorable and that the unfavorable enthalpy originates from the energy cost of rearranging the flap region in the protease molecule. In addition, the binding is coupled to a negative heat capacity change. The dominant binding force is the increase in solvent entropy that accompanies the burial of a significant hydrophobic surface. Comparison of the binding energetics obtained for the substrate with that obtained for synthetic nonpeptide inhibitors indicates that the major difference is in the magnitude of the conformational entropy change. In solution, the peptide substrate has a higher flexibility than the synthetic inhibitors and therefore suffers a higher conformational entropy loss upon binding. This higher entropy loss accounts for the lower binding affinity of the substrate. On the other hand, due to its higher flexibility, the peptide substrate is more amenable to adapt to backbone rearrangements or subtle conformational changes induced by mutations in the protease. The synthetic inhibitors are less flexible, and their capacity to adapt is more restricted. The expected result is a more pronounced effect of mutations on the binding affinity of the synthetic inhibitors. On the basis of the thermodynamic differences in the mode of binding of substrate and synthetic inhibitors, it appears that a key factor to understanding resistance is given by the relative balance of the different forces that contribute to the binding free energy and, in particular, the balance between conformational and solvation entropy.
通过直接微量热分析测定了HIV-1蛋白酶抑制剂乙酰胃蛋白酶抑制剂与底物Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln(对应于gag、gag-pol多蛋白中一个切割位点)的结合热力学。结果表明,肽底物或肽抑制剂的结合是由熵驱动的;即,其特征是焓变不利而熵变有利,这与基于能量学经验参数化的基于结构的热力学分析一致。对结合焓的剖析表明,内在相互作用是有利的,不利的焓源于蛋白酶分子中瓣区重排的能量成本。此外,结合与负的热容变化相关。主要的结合力是伴随着显著疏水表面埋藏的溶剂熵增加。将底物的结合能与合成非肽抑制剂的结合能进行比较表明,主要差异在于构象熵变的大小。在溶液中,肽底物比合成抑制剂具有更高的灵活性,因此在结合时遭受更高的构象熵损失。这种更高的熵损失解释了底物较低的结合亲和力。另一方面,由于其更高的灵活性,肽底物更易于适应蛋白酶中突变引起的主链重排或细微构象变化。合成抑制剂的灵活性较低,其适应能力更受限制。预期结果是突变对合成抑制剂结合亲和力的影响更为显著。基于底物和合成抑制剂结合模式的热力学差异,似乎理解耐药性的一个关键因素是由促成结合自由能的不同力的相对平衡给出的,特别是构象熵和溶剂化熵之间的平衡。